QQ客服 官方微博 反馈留言

	The Association Between Phosphodiesterase Type 5 Inhibitor Use and Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Meta-Analysis
	Liu, Bing[1]; Zhu, Linxin[1]; Zhong, Jingxiang[1]; Zeng, Guohua[2,3,4]; Deng, Tuo[2,3,4]
	2018
卷号	6期号:3页码:185
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4629137
专题	暨南大学
作者单位	1.[1]Jinan Univ, Dept Ophthalmol, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China 2.[2]Guangzhou Med Univ, Dept Urol, Minimally Invas Surg Ctr, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China 3.[3]Guangzhou Inst Urol, Guangzhou, Guangdong, Peoples R China 4.[4]Guangdong Key Lab Urol, Guangzhou, Guangdong, Peoples R China
推荐引用方式 GB/T 7714	Liu, Bing[1],Zhu, Linxin[1],Zhong, Jingxiang[1],et al. The Association Between Phosphodiesterase Type 5 Inhibitor Use and Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Meta-Analysis[J],2018,6(3):185.
APA	Liu, Bing[1],Zhu, Linxin[1],Zhong, Jingxiang[1],Zeng, Guohua[2,3,4],&Deng, Tuo[2,3,4].(2018).The Association Between Phosphodiesterase Type 5 Inhibitor Use and Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Meta-Analysis.,6(3),185.
MLA	Liu, Bing[1],et al."The Association Between Phosphodiesterase Type 5 Inhibitor Use and Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Meta-Analysis".6.3(2018):185.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。